The suspension, imposed in January over delayed annual accounts, is lifted after the company approves its audited results
June 27, 2026
Staff Correspondent
bdnews24.com
Beximco Pharmaceuticals Limited has resumed trading on the London Stock Exchange after a suspension of nearly six months over its failure to publish annual financial results on time.
The exchange lifted the freeze on Friday, with trading in the company's Global Depositary Receipts (GDRs) resuming on the Alternative Investment Market (AIM) on Friday and Saturday.
Regulator warns delisting would hurt Bangladesh’s capital market reputation
Recognising the urgency, DBA President Saiful Islam led swift coordination between BSEC and BEXIMCO Pharmaceuticals' management…
Shares of Beximco Pharmaceuticals gained 8 percent over the last two trading sessions on the Dhaka Stock Exchange (DSE), closing…
Shares of Beximco Pharmaceuticals gained 8 percent over the last two trading sessions on the Dhaka Stock Exchange (DSE), closing…
Shares of Beximco Ltd and Islami Bank fell the most among all listed firms on the first trading day after the stock regulator…
The stock closes at Tk 42.90, extending a sharp slide that leaves it among the market’s worst performers
DBA intervention saves BEXIMCO Pharma GDR from London delisting
Dhaka, Ctg bourses get power to set market control parameters
SEC grants fresh licences to BGL firms, clears return to capital market operations
Beximco Pharma launches 96% cheaper drug for rare disease
117-year-old bourse Calcutta Stock Exchange eyeing a revival under new Bengal govt
BSE announces change in licensing requirements for market data products from Jan 2027
Will Calcutta Stock Exchange make a comeback?
Corporate Travel to miss re-listing deadline as customers quibble
Three dozen listed firms still have not filed FY25 reports
Gibo Holdings Ltd trading halted, news pending
